RSCM
IMDZ

Rock Springs Capital Management’s Immune Design Corp. IMDZ Stock Holding History

Rock Springs Capital Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-55,000
Closed -$1.14M – 134
2015
Q2 		$1.14M Buy
+55,000
New +$1.3M 0.08% 116

Other funds holding IMDZ

CGL
Column Group LP San Francisco, California $38.6M AUM 30.92% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Rock Springs Capital Management's IMDZ Position: Q3 2015 in Review

Rock Springs Capital Management sold out of Immune Design Corp. (IMDZ) in Q3 2015, closing a stake of 55,000 shares — an estimated $1.14M sold.

Rock Springs Capital Management first reported a position in IMDZ in Q2 2015 and held it in 1 quarter. The position peaked at $1.14M in Q2 2015. 59 funds tracked by Wall St. Rank hold IMDZ as of Q3 2015.

  • Rock Springs Capital Management reported no remaining Immune Design Corp. position as of Q3 2015 after selling out during the quarter.
  • Rock Springs Capital Management sold 55,000 Immune Design Corp. shares in Q3 2015, an estimated $1.14M.
  • Rock Springs Capital Management first reported a position in Immune Design Corp. in Q2 2015 and held it in 1 quarter.
  • Rock Springs Capital Management's Immune Design Corp. position peaked at $1.14M in Q2 2015.
  • 59 funds tracked by Wall St. Rank held Immune Design Corp. as of Q3 2015.

Based on Rock Springs Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.